Neuronetics Inc. (STIM)
STIM trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.99
-6.57% on the day
Market cap
$151.6M
Micro cap
Revenue · 2025
$149.2M
+99.2% on 2024
Net income · 2025
-$39.0M
-26.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | STIM on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001227636 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $149.2M |
| Net income | -$39.0M |
| Operating income | -$31.4M |
| Net margin | -26.1% |
| Operating margin | -21.1% |
| Revenue growth | +99.2% |
| Cash | $28.1M |
| Total assets | $141.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-03-17 |
| Latest annual report | 10-K | 2026-03-17 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-17 |
| Latest proxy | DEFA14A | 2026-04-09 |
Source: SEC EDGAR submissions feed, 716 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| KRMD | KORU Medical Systems Inc. Common Stock (DE) | $3.00 | +1.01% | $138.5M |
| NYXH | Nyxoah SA | $1.28 | -2.29% | $128.1M |
| LUCD | Lucid Diagnostics Inc. | $0.6060 | +1.44% | $123.2M |
| PDEX | Pro-Dex Inc. | $62.27 | -1.30% | $201.3M |
| SKYA | SkyAI Inc. | $2.61 | +0.39% | $112.9M |
| APYX | Apyx Medical Corporation | $2.60 | -1.89% | $109.5M |
| PYPD | PolyPid Ltd. | $4.88 | -2.79% | $99.1M |
| UTMD | Utah Medical Products Inc. | $74.71 | +0.40% | $237.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier